FOXM1 and breast cancer: As FOXM1 itself is a poor prognosis marker in ERα breast cancer (Figure S8 in Additional file 1) we tested whether the genes regulated by thiostrepton and with a FOXM1 binding site within 50 kb of the TSS were correlated with clinical outcome in breast cancer.